Thomas Ebeling - 23 May 2024 Form 4 Insider Report for Cullinan Therapeutics, Inc. (CGEM)

Role
Director
Signature
/s/ Jacquelyn Sumer, Attorney-in-Fact
Issuer symbol
CGEM
Transactions as of
23 May 2024
Net transactions value
+$571,890
Form type
4
Filing time
23 May 2024, 16:11:26 UTC
Previous filing
12 Jun 2023
Next filing
11 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CGEM Common Stock Award $362,163 +84,224 +125% $4.30 151,728 23 May 2024 Direct
transaction CGEM Common Stock Award $209,727 +16,475 +11% $12.73 168,203 23 May 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CGEM Stock Option (Right to Buy) Options Exercise $0 -84,224 -100% $0.000000* 0 23 May 2024 Common Stock 84,224 $4.30 Direct F1
transaction CGEM Stock Option (Right to Buy) Options Exercise $0 -16,475 -100% $0.000000* 0 23 May 2024 Common Stock 16,475 $12.73 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares vested on August 16, 2018, and the remaining shares vested in 36 equal monthly installments thereafter.